Utilizing principal component analysis in the identification of clinically relevant changes in patient HLA single...

Area of Science:

• Transplant Immunology
• Machine Learning in Healthcare
• Immunogenetics

Background:

• Human leukocyte antigen (HLA) antibody testing is critical for solid-organ transplant allocation, patient monitoring, and risk assessment.
• Luminex solid-phase testing is standard for HLA antibody identification but involves complex manual analysis of over 90 specificities.
• Principal component analysis (PCA) is a machine learning technique for extracting features from high-dimensional data.

Purpose of the Study:

• To evaluate the utility of PCA-derived analysis in characterizing HLA antibody patterns in solid organ transplant patients.
• To compare PCA-derived analysis against a control group of pre- and post-transplant patients.
• To establish a threshold for PCA-derived analysis indicating significant changes in single antigen bead patterns.

Main Methods:

• Applied PCA to HLA antibody test results from solid organ transplant patients, including those with donor-specific antibodies (DSAs).
• Utilized Receiver Operating Characteristic (ROC) analysis to determine a threshold for PCA-derived analysis.
• Compared PCA-derived analysis results with clinical outcomes to assess its ability to identify new HLA antibody reactivity.

Main Results:

• The PCA-derived algorithm demonstrated 100% sensitivity and 75% specificity in identifying new HLA antibody reactivity.
• Positive Predictive Value (PPV) was 65% and Negative Predictive Value (NPV) was 100% for detecting changes from a patient's historical HLA antibody pattern.
• PCA analysis also identified over-reactive single antigen beads in both HLA class I and II panels, suggesting potential assay interference.

Conclusions:

• PCA-derived analysis can automate the identification of significant changes in HLA antibody patterns, including DSAs and de novo antibodies.
• This method aids in detecting assay interference and over-reactive beads in HLA antibody testing.
• PCA offers a valuable tool for improving transplant patient monitoring and understanding assay performance.